Silk-brand chocolate soymilk recalled

Apr 24, 2008

The U.S. Food and Drug Administration announced the voluntary nationwide recall of Silk-brand chocolate flavor soymilk due to a labeling error.

The FDA said the WhiteWave Foods Co. of Broomfield, Colo., is recalling 11-ounce plastic single serve bottles of Silk Soymilk Chocolate Flavor because they might contain undeclared milk protein, posing a health risk to people allergic to that ingredient.

The recalled bottles are printed with both a "use by" date of "05 07 08" and a UPC of 2529360028.

The product can be return to the place of purchase for a refund or exchange. Consumers with questions can contact the company at 800-587-2259.

Copyright 2008 by United Press International

Explore further: Allergan to cut 1,500 employees in restructuring (Update)

add to favorites email to friend print save as pdf

Related Stories

New study refines biological evolution model

56 minutes ago

Models for the evolution of life are now being developed to try and clarify the long term dynamics of an evolving system of species. Specifically, a recent model proposed by Petri Kärenlampi from the University ...

As numbers of gray seals rise, so do conflicts

21 hours ago

(AP)—Decades after gray seals were all but wiped out in New England waters, the population has rebounded so much that some frustrated residents are calling for a controlled hunt.

Recommended for you

Face transplants change lives, identity

5 hours ago

Patients are prepared to take significant risks in order to be considered for a face transplant, says Dr David Koppel, director of the largest craniofacial unit in the UK and Honorary Clinical Associate Professor ...

British Lords hold ten-hour debate on assisted dying

Jul 19, 2014

Members of Britain's unelected House of Lords spent almost ten hours on Friday discussing whether to legalise assisted dying, in an often emotional debate putting the question back on the agenda, if not on the statute books.

AbbVie, Shire agree on $55B combination

Jul 18, 2014

The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.

User comments : 0